ANNE D DONOVAN

Allopathic & Osteopathic Physicians|Family Medicine WALTON, KY NPI 1124061981

General Payments — all program years on this page

$1,916.83

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 76
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $587.74 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $587.7410

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Axsome Therapeutics, Inc. $226.212
Acerta Pharma LLC $138.412
ABBVIE INC. $120.011
Amgen Inc. $30.331
Novo Nordisk AS $23.401
Abbott Laboratories $18.431
Astellas Pharma US Inc $16.681
GlaxoSmithKline, LLC. $14.271

By program year

Program yearAmountRecords
2018 $145.747
2019 $36.402
2020 $243.0615
2021 $252.3715
2022 $223.6813
2023 $427.8414
2024 $587.7410

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097488002 Novo Nordisk Inc $23.40 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103653066 ABBVIE INC. $120.01 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104587750 AstraZeneca Pharmaceuticals LP $18.71 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105466517 AstraZeneca Pharmaceuticals LP $119.70 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116650101 GlaxoSmithKline, LLC. $14.27 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117241020 Amgen Inc. $30.33 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124855067 Abbott Laboratories $18.43 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139344256 Astellas Pharma US Inc $16.68 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148264955 Axsome Therapeutics, Inc. $119.70 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148264957 Axsome Therapeutics, Inc. $106.51 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.